[ad_1]
The surge in interest investors have displayed for companies delivering weight loss drugs has been impressive. Indeed, the growth various weight loss drugs have seen is notable, with GLP-1 agonists like Ozempic, Wegovy, and Zepbound seeing incredible demand. The revenue and profitability surges…
[ad_2]
Source link
